Shufersal Group reports results for Q4 and FY 2023: Revenues of ~15.2B NIS and net profit of ~323M NIS

In This Article:

Improvement in the quarterly profit - Shufersal's net profit for Q4 totaled ~133M NIS, and is an improvement for the company.

Improvement in the quarterly profit for the company compared net profits of ~3M NIS in the respective quarter in 2022

Revenues in Q4 grew by ~7%, totaling ~3.9B NIS, compared to ~3.65NIS in the respective quarter last year

The rate of expenses of the group's total revenues decreased by approximately 1.9% in 2023 and is significantly lower by approximately 66 million NIS compared to 2022; in 2023 the group reduced the number of employees to approximately 15,800 compared to approximately 16,545 employees in 2022

~6.9% growth in same store sales in Q3 2023 with an operating profit rate of 3.7% of revenues in the retail sector for the said quarter

Increase in operating profit (before other income/expenses) in Q4, totaling ~244 NIS, comprising ~6.2% of the income compared to ~70M NIS in the respective quarter last year, ~2.2% of the revenues

Increase in operating profit (before other income/expenses) in 2023, totaling ~707M NIS, comprising ~4.7% of the income compared to ~283M NIS in the respective year, ~1.9% of the revenues

The operating profit of the Be Pharm grew and amounted to ~17 million NIS in 2023 compared to ~3 million NIS in 2022

The Company board of directors has decided on a dividend distribution of ~180M NIS 

(*) Starting with the 2023 financial statements, the segment reporting data (including the comparison numbers) include the impact of the implementation of IFRS16

TEL AVIV, Israel, March 27, 2024 /PRNewswire/ -- Shufersal (TASE: SAE), Israel's leading retailer, announced today financial results for the fourth quarter and full year of 2023.

Shufersal Logo
Shufersal Logo

Itzik Abercohen, Chairman of Shufersal and Ori Watermann, CEO of Shufersal Group:

"We are concluding 2023 with robust results that reflect the Group's resumption to growth. We have ended the year with an increase in revenues to the record presented in 2020 and have demonstrated improvements in all profit metrics pursuant to the streamlining and improved working capital measures taken, thus reducing the net financial debt to ~1.2B NIS. The Group continued to focus on food retail, streamlining and improving its operating profitability while further developing various growth areas. Q4 was impacted by Iron Swords War, providing a strong end to the year, both in the same stores, with a sharp increase in demands, and in the net profit for Q4, reflecting a quarterly record for the Group.

2023 was characterized by a technological upswing upon launching the automatic delivery center in Modi'in. We continued to strengthen the online and digital infrastructures, aiming to achieve leadership in the field while enhancing synergies with BePharm. Activities in the business sector are also expanding, and we are also working on expanding the scope of the private institutional brand. Stock chain operations are gaining momentum as we open new branches and establish a synergy with the retail operation. In addition, the low leverage and liquid balances enable the Group to develop in real estate, while improving existing properties and harnessing market opportunities.